L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice

Circulation

Volumn 95, Issue 2, 1997, Pages 430-437

  Aji, Walif ^a   Ravalli, Stefano ^a   Szabolcs, Matthias ^a   Jiang, Xian Cheng ^a   Sciacca, Robert R ^a   Michler, Robert E ^a   Cannon, Paul J ^a,b  

^a The New York Presbyterian Hospital   (United States)

^b Columbia University ^*  (United States)

Author keywords

atherosclerosis; genes; hypercholesterolemia; L arginine; nitric oxide synthase

Indexed keywords

ARGININE; CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DIET SUPPLEMENTATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; XANTHOMA;

EID: 0031023733     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.2.430     Document Type: Article

References (13)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
3. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet. 1994;793-795.
4. Goldstein JL, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Benedet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York, NY: McGraw-Hill Publishing Co; 1989:1215-1250.
5. Watanabe Y, Ito T, Shiomi M. The effect of selective breeding on the development of coronary atherosclerosis in WHHL rabbits: an animal model for familial hypercholesterolemia. Atherosclerosis. 1985;56:71-97.
6. Scanu AM, Khalil A, Neven L, Tidore M, Dawson G, Pfaffinger D, Jackson E, Carey KD, McGill HC, Fleiss CM. Genetically determined hypercholesterolemia in a rhesus monkey family due to a deficiency of the LDL receptor. J Lipid Res. 1988;29:1671-1681.
7. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest. 1993;92:883-893.
8. Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DK. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest. 1994;93:1885-1893.
9. Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol. 1990;30:535-560.
10. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142.
11. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992;6:3051-3064.
12. Wilcox JN, Subramanian RR, Ross CE, Tracey WR, Pollack JS, Harrison DG, Marsden PA. Expression of multiple nitric oxide synthase isoforms in human aortic fatty streaks and advanced atherosclerotic plaques. Circulation. 1994;90(suppl 1):I-298. Abstract.
13. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA. 1990;87:1620-1624.